Catalyst Wire Dossier Catalyst Wire Dossier

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

· Promentis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal, covering 2020-07-17 to 2020-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal [Phase 2]

See pricing